These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24777259)

  • 1. Safety of onabotulinum toxin a injection to the central upper eyelid and eyebrow regions.
    Huang L; Costin BR; Sakolsatayadorn N; Perry JD
    Ophthalmic Plast Reconstr Surg; 2014; 30(5):377-80. PubMed ID: 24777259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re: "safety of onabotulinum toxin A injection to the central upper eyelid and eyebrow regions".
    Steinsapir KD
    Ophthalmic Plast Reconstr Surg; 2015; 31(2):160-1. PubMed ID: 25746898
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: "Safety of Onabotulinum Toxin A Injections to the Central Upper Eyelid and Eyebrow Regions".
    Burroughs JR; Hsueh JB; Soparkar CN; McCann JD
    Ophthalmic Plast Reconstr Surg; 2015; 31(5):422. PubMed ID: 26352526
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
    Cakmur R; Ozturk V; Uzunel F; Donmez B; Idiman F
    J Neurol; 2002 Jan; 249(1):64-8. PubMed ID: 11954870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH; Cetinkaya A; Kulwin DR
    Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of preseptal and pretarsal onabotulinum toxin an injection in patients with hemifacial spasm.
    Yılmaz ATC; Yılmaz M; Öztekin MF
    Int J Neurosci; 2021 Jun; 131(6):549-554. PubMed ID: 32233985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative crossover study on the treatment of hemifacial spasm and blepharospasm: preseptal and pretarsal botulinum toxin injection techniques.
    Lolekha P; Choolam A; Kulkantrakorn K
    Neurol Sci; 2017 Nov; 38(11):2031-2036. PubMed ID: 28884242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term enhancement of botulinum toxin injections by upper-eyelid surgery in 14 patients with facial dyskinesias.
    Mauriello JA; Keswani R; Franklin M
    Arch Otolaryngol Head Neck Surg; 1999 Jun; 125(6):627-31. PubMed ID: 10367918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of botulinum toxin A in the treatment of hemifacial spasm and blepharospasm.
    Chang LB; Tsai CP; Liao KK; Kao KP; Yuan CL; Yen DJ; Lin KP
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jan; 62(1):1-5. PubMed ID: 10063705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An objective tool to measure the effect of botulinum toxin in blepharospasm and hemifacial spasm.
    Osaki MH; Osaki TH; Garcia DM; Osaki T; Gameiro G; Belfort R; Cruz AAV
    Eur J Neurol; 2020 Aug; 27(8):1487-1492. PubMed ID: 32294304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cosmetic Microdroplet Botulinum Toxin A Forehead Lift: A New Treatment Paradigm.
    Steinsapir KD; Rootman D; Wulc A; Hwang C
    Ophthalmic Plast Reconstr Surg; 2015; 31(4):263-8. PubMed ID: 25216199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anesthesia with EMLA cream for botulinum A toxin injection into eyelids.
    Söylev MF; Koçak N; Kuvaki B; Ozkan SB; Kir E
    Ophthalmologica; 2002; 216(5):355-8. PubMed ID: 12424403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of flexible onabotulinum toxin A treatment in facial dystonia.
    Bladen JC; Feldman I; Favor M; Dizon M; Litwin A; Malhotra R
    Eye (Lond); 2019 Mar; 33(3):349-352. PubMed ID: 30202071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eighteen-point abobotulinum toxin a upper face rejuvenation: an eye plastic perspective on 845 subjects.
    Kashkouli MB; Amani A; Jamshidian-Tehrani M; Yousefi S; Jazayeri AA
    Ophthalmic Plast Reconstr Surg; 2014; 30(3):219-24. PubMed ID: 24481513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Safety and efficacy of botulinum toxin in hemifacial spasm].
    Mazlout H; Kamoun Gargouri H; Triki W; Kéfi S; Brour J; El Afrit MA; Chéour M; Kraiem A
    J Fr Ophtalmol; 2013 Mar; 36(3):242-6. PubMed ID: 23270989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of brow lifting using botulinum a toxin on upper eyelid height in patients with ptosis undergoing the frontal sling technique.
    Isik D; Tekin H; Karadag R; Bilgili SG; Atik B
    Ann Plast Surg; 2013 Feb; 70(2):175-9. PubMed ID: 22791060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysport (botulinum toxin type A) in routine therapeutic usage: a telephone needs assessment survey of European physicians to evaluate current awareness and adherence to product labeling changes.
    Hubble J; Schwab J; Hubert C; Abbott CC
    Clin Neuropharmacol; 2013; 36(4):122-7. PubMed ID: 23783005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm.
    Wu CJ; Shen JH; Chen Y; Lian YJ
    Turk Neurosurg; 2011; 21(4):625-9. PubMed ID: 22194126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy of local doxorubicin chemomyectomy in patients with blepharospasm and hemifacial spasm.
    Wirtschafter JD; McLoon LK
    Ophthalmology; 1998 Feb; 105(2):342-6. PubMed ID: 9479297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of upper eyelid myectomy on subsequent chemodenervation in the management of benign essential blepharospasm.
    Kent TL; Petris CK; Holds JB
    Ophthalmic Plast Reconstr Surg; 2015; 31(3):222-6. PubMed ID: 25192329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.